SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,490,931 | -38.9% | 10,204,375 | -5.8% | 0.04% | -34.5% |
Q2 2023 | $64,583,520 | +81.6% | 10,836,161 | -0.4% | 0.06% | +71.9% |
Q1 2023 | $35,567,558 | -16.4% | 10,876,929 | +1.0% | 0.03% | -27.3% |
Q4 2022 | $42,520,672 | -35.4% | 10,764,727 | -1.8% | 0.04% | -35.3% |
Q3 2022 | $65,800,000 | -7.1% | 10,966,736 | -0.4% | 0.07% | -6.8% |
Q2 2022 | $70,804,000 | -22.7% | 11,011,462 | -0.7% | 0.07% | +14.1% |
Q1 2022 | $91,569,000 | -47.5% | 11,085,861 | -1.6% | 0.06% | -33.3% |
Q4 2021 | $174,337,000 | -30.8% | 11,262,030 | +0.6% | 0.10% | -27.3% |
Q3 2021 | $251,995,000 | +14.0% | 11,189,832 | -0.5% | 0.13% | +22.2% |
Q2 2021 | $221,014,000 | -33.9% | 11,241,851 | +12.6% | 0.11% | -42.2% |
Q1 2021 | $334,284,000 | – | 9,987,545 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 25,001,856 | $96,757,183 | 7.02% |
Omega Fund Management, LLC | 843,750 | $3,265,313 | 3.00% |
Crestline Management, LP | 3,365,624 | $13,024,965 | 1.52% |
Trustees of Columbia University in the City of New York | 98,353 | $380,626 | 0.70% |
Alphabet Inc. | 2,812,500 | $10,884,375 | 0.70% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,963,704 | $11,469,534 | 0.62% |
Casdin Capital, LLC | 750,000 | $2,902,500 | 0.32% |
PFM Health Sciences, LP | 1,244,139 | $4,814,818 | 0.23% |
HARBOURVEST PARTNERS LLC | 137,694 | $532,876 | 0.18% |
GSA CAPITAL PARTNERS LLP | 540,250 | $2,091 | 0.18% |